{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:26:35Z","timestamp":1784003195322,"version":"3.55.0"},"reference-count":47,"publisher":"BMJ","issue":"7","funder":[{"name":"the National Key Technology Research and Development Program of the Ministry of Science and Technology of China"},{"name":"the Jiangsu Provincial clinical science and technology project"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,6,14]]},"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the clinical features, pathological presentations, treatments and outcomes of lupus nephritis (LN) with anti-neutrophil cytoplasmic antibody (ANCA) positivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A case\u2013control study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients (n=49) were retrospectively included from Jinling Hospital in China if presenting with biopsy-proven ANCA-positive LN between 1985 and 2008. Clinicopathological characteristics and outcomes were analysed and compared with those of a control group (n=1279). We further compared treatment responses and outcomes of ANCA-positive LN patients based on the treatment issued.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 40 women and 9 men (median age 33 years at biopsy): 38 with myeloperoxidase (MPO)-ANCA, 7 with proteinase 3\n                      <jats:underline>(<\/jats:underline>\n                      PR3)-ANCA and 4 with double positivity. ANCA-positive LN patients exhibited higher haematuria, serum creatinine levels and systemic lupus erythematosus disease activity index scores. On pathological evaluation, class IV LN was predominant, accounting for 61.22% of cases. Light microscopy revealed significantly higher activity index and chronicity index scores, including cellular crescents, interstitial inflammation, tubular atrophy and interstitial fibrosis. ANCA-positive LN patients receiving mycophenolate mofetil as induction therapy had a higher remission rate and better renal outcomes than those receiving cyclophosphamide. During follow-up, end-stage renal disease developed in seven (14.29%) ANCA-positive LN patients, all of them were MPO-ANCA positive.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The characteristics of ANCA-positive LN were massive haematuria and advanced renal insufficiency. We observed a higher remission rate and better prognoses when using mycophenolate mofetil than when using cyclophosphamide as induction therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-015668","type":"journal-article","created":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T20:10:21Z","timestamp":1501359021000},"page":"e015668","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case\u2013control study"],"prefix":"10.1136","volume":"7","author":[{"given":"Cui","family":"Li","sequence":"first","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Lin","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Dan","family":"Liang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Hong","family":"Zeng","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Tao","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"2025121514004581000_7.7.e015668.1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013010026"},{"key":"2025121514004581000_7.7.e015668.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603063141004"},{"key":"2025121514004581000_7.7.e015668.3","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.318"},{"key":"2025121514004581000_7.7.e015668.4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014090903"},{"key":"2025121514004581000_7.7.e015668.5","first-page":"264","article-title":"Anti-neutrophil cytoplasmic antibody positivity in five children with systemic lupus erythematosus--what is the importance of this finding?","volume":"22","author":"Bobek","year":"2014","journal-title":"Acta Dermatovenerol Croat"},{"key":"2025121514004581000_7.7.e015668.6","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s00296-011-2055-z","article-title":"Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?","volume":"32","author":"Hervier","year":"2012","journal-title":"Rheumatol Int"},{"key":"2025121514004581000_7.7.e015668.7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10753-008-9073-3","article-title":"Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis","volume":"31","author":"Pan","year":"2008","journal-title":"Inflammation"},{"key":"2025121514004581000_7.7.e015668.8","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04391007"},{"key":"2025121514004581000_7.7.e015668.9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00467-003-1365-0","article-title":"A boy with consecutive development of SLE and Wegener granulomatosis","volume":"19","author":"Erdo\u011fan","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"2025121514004581000_7.7.e015668.10","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu456rr"},{"key":"2025121514004581000_7.7.e015668.11","doi-asserted-by":"publisher","DOI":"10.1007\/s002960100108"},{"key":"2025121514004581000_7.7.e015668.12","doi-asserted-by":"publisher","DOI":"10.1159\/000013557"},{"key":"2025121514004581000_7.7.e015668.13","first-page":"2480","article-title":"Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus in childhood","volume":"26","author":"Faure-Fontenla","year":"1999","journal-title":"J Rheumatol"},{"key":"2025121514004581000_7.7.e015668.14","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050060"},{"key":"2025121514004581000_7.7.e015668.15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.11.2821"},{"key":"2025121514004581000_7.7.e015668.16","first-page":"541","article-title":"Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE","volume":"16","author":"Galeazzi","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"2025121514004581000_7.7.e015668.17","doi-asserted-by":"publisher","DOI":"10.1007\/BF02238766"},{"key":"2025121514004581000_7.7.e015668.18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0272-6386(97)90018-4","article-title":"Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis","volume":"29","author":"Marshall","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"2025121514004581000_7.7.e015668.19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.1780380509","article-title":"Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus","volume":"38","author":"Schnabel","year":"1995","journal-title":"Arthritis & Rheumatism"},{"key":"2025121514004581000_7.7.e015668.20","first-page":"1670","article-title":"Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus","volume":"21","author":"Pauzner","year":"1994","journal-title":"J Rheumatol"},{"key":"2025121514004581000_7.7.e015668.21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/31.10.669"},{"key":"2025121514004581000_7.7.e015668.22","doi-asserted-by":"crossref","first-page":"e2580","DOI":"10.1097\/MD.0000000000002580","article-title":"Clinicopathologic Characteristics and Outcomes of Lupus Nephritis With Antineutrophil Cytoplasmic Antibody","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"2025121514004581000_7.7.e015668.23","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315593166"},{"key":"2025121514004581000_7.7.e015668.24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025121514004581000_7.7.e015668.25","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.70"},{"key":"2025121514004581000_7.7.e015668.26","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.75"},{"key":"2025121514004581000_7.7.e015668.27","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1681\/ASN.V481499","article-title":"Renal vascular complications of systemic lupus erythematosus","volume":"4","author":"Appel","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"2025121514004581000_7.7.e015668.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"key":"2025121514004581000_7.7.e015668.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70262-9"},{"key":"2025121514004581000_7.7.e015668.30","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025121514004581000_7.7.e015668.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"2025121514004581000_7.7.e015668.32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0272-6386(12)70314-1","article-title":"Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases","volume":"22","author":"Sinico","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"2025121514004581000_7.7.e015668.33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11255-014-0903-y","article-title":"Clinicopathological and outcome analysis of adult lupus nephritis patients in China","volume":"47","author":"Tang","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"2025121514004581000_7.7.e015668.34","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328349a1e5"},{"key":"2025121514004581000_7.7.e015668.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2008.00975.x"},{"key":"2025121514004581000_7.7.e015668.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2005.01.015"},{"key":"2025121514004581000_7.7.e015668.37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker205"},{"key":"2025121514004581000_7.7.e015668.38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31817c744b"},{"key":"2025121514004581000_7.7.e015668.39","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu237"},{"key":"2025121514004581000_7.7.e015668.40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131038"},{"key":"2025121514004581000_7.7.e015668.41","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01020113"},{"key":"2025121514004581000_7.7.e015668.42","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1681\/ASN.V9101915","article-title":"Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis","volume":"9","author":"Franssen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2025121514004581000_7.7.e015668.43","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.108"},{"key":"2025121514004581000_7.7.e015668.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2009.01100.x"},{"key":"2025121514004581000_7.7.e015668.45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V121134","article-title":"Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis","volume":"12","author":"Hogan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2025121514004581000_7.7.e015668.46","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.103"},{"key":"2025121514004581000_7.7.e015668.47","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.132"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-015668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:00:55Z","timestamp":1765836055000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-015668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,28]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/bmjopen-2016-015668"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-015668","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}